Concepedia

Robert M. Gill

RM

Statistics

Publications

21

Citations

1K

H-Index

19

Active since

1985

Affiliations

Eli Lilly (United States)(Current)

Memorial University of Newfoundland

Columbia University

Zorg voor innoveren

Robert M. Gill is an author at Eli Lilly (United States) specializing in medicine, cardiology, and physiology.

Publications per year

1985–2020

21

Publications

21

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases

Thales Papagiannakopoulos, Dinorah Friedmann‐Morvinski, Pierre Neveu et al. · Oncogene · 2011 · 185 citations · Full text

, , +15

Ventricular refractory period extension caused by defibrillation shocks.

Robert J. Sweeney, Robert M. Gill, Mitchell I. Steinberg et al. · Circulation · 1990 · 119 citations · Full text

, , +11

Interruption of sympathetic and vagal-mediated afferent responses by transmural myocardial infarction.

Michael Barber, Timothy Mueller, Ben Davies et al. · Circulation · 1985 · 113 citations · Full text

, , +12

The GLP-1 Receptor Agonist Liraglutide Increases Myocardial Glucose Oxidation Rates via Indirect Mechanisms and Mitigates Experimental Diabetic Cardiomyopathy

Malak Almutairi, Keshav Gopal, Amanda A. Greenwell et al. · Canadian Journal of Cardiology · 2020 · 72 citations

, , +14

Characterization of refractory period extension by transcardiac shock.

Robert J. Sweeney, Robert M. Gill, Philip R. Reid · Circulation · 1991 · 59 citations · Full text

, , +10

1–5 of 21